DNA transfer in the skin

Dermatologic, Cosmeceutic, and Cosmetic Development: Therapeutic and Novel Approaches

Volumn , Issue , 2007, Pages 537-556

  Vandermeulen, Gaëlle ^a   Daugimont, Liévin ^a   Préat, Véronique ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67349185498     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (111)

1. Spirito F, Meneguzzi G, Danos O, et al. Cutaneous gene transfer and therapy: the present and the future. J Gene Med 2001; 3(1):21-31.
2. Hengge UR. Gene therapy progress and prospects: the skin-easily accessible, but still far away. Gene Ther 2006; 13(22):1555-1563.
3. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247(4949 Pt 1):1465-1468.
4. Jeschke MG, Herndon DN, Baer W, et al. Possibilities of non-viral gene transfer to improve cutaneous wound healing. Curr Gene Ther 2001; 1(3):267-278.
5. Branski LK, Pereira CT, Herndon DN et al. Gene therapy in wound healing: present status and future directions. Gene Ther 2007; 14(1):1-10.
6. Meng X, Sawamura D, Ina S, et al. Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin. Exp Dermatol 2002; 11(5):456-461.
7. Sawamura D, Akiyama M, Shimizu H. Direct injection of naked DNA and cytokine transgene expression: implications for keratinocyte gene therapy. Clin Exp Dermatol 2002; 27(6):480-484.
8. Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992; 356(6365):152-154.
9. Cui Z, Sloat BR. Topical immunization onto mouse skin using a microemulsion incorporated with an anthrax protective antigen protein-encoding plasmid. Int J Pharm 2006; 317(2):187-191.
10. Hengge UR, Bardenheuer W. Gene therapy and the skin. Am J Med Genet C Semin Med Genet 2004; 131C(1):93-100.
11. Yu WH, Kashani-Sabet M, Liggitt D, et al. Topical gene delivery to murine skin. J Invest Dermatol 1999; 112(3):370-375.
12. Kang MJ, Kim CK, Kim MY, et al. Skin permeation, biodistribution, and expression of topically applied plasmid DNA. J Gene Med 2004; 6(11):1238-1246.
13. Fan H, Lin Q, Morrissey GR, et al. Immunization via hair follicles by topical application of naked DNA to normal skin. Nat Biotechnol 1999; 17(9):870-872.
14. Felgner PL. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci 1987; 84:7413-7417.
15. Alexander MY, Akhurst RJ. Liposome-medicated gene transfer and expression via the skin. Hum Mol Genet 1995; 4(12):2279-2285.
16. Li L, Hoffman RM. The feasibility of targeted selective gene therapy of the hair follicle. Nat Med 1995; 1(7):705-706.
17. Sawamura D, Meng X, Ina S, et al. In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. J Invest Dermatol 1997; 108(2):195-199.
18. Raghavachari N, Fahl WE. Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles. J Pharm Sci 2002; 91(3):615-622.
19. Meykadeh N, Mirmohammadsadegh A, Wang Z, et al. Topical application of plasmid DNA to mouse and human skin. J Mol Med 2005; 83(11):897-903.
20. Babiuk S, Baca-Estrada ME, Pontarollo R et al. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J Pharm Pharmacol 2002; 54(12):1609-1614.
21. Kirjavainen M, Urtti A, Valjakka-Koskela R, et al. Liposome-skin interactions and their effects on the skin permeation of drugs. Eur J Pharm Sci 1999; 7(4):279-286.
22. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst 1996; 13(3-4):257-388.
23. Kim A, Lee EH, Choi SH, et al. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 2004; 25(2):305-313.
24. Lee EH, Kim A, Oh YK, et al. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 2005; 26(2):205-210.
25. Wu H, Ramachandran C, Bielinska AU, et al. Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm 2001; 221(1-2):23-34.
26. Cui Z, Fountain W, Clark M, et al. Novel ethanol-in-fluorocarbon microemulsions for topical genetic immunization. Pharm Res 2003; 20(1):16-23.
27. Heckert RA, Elankumaran S, Oshop GL, et al. A novel transcutaneous plasmid-dimethylsulfoxide delivery technique for avian nucleic acid immunization. Vet Immunol Immunopathol 2002; 89(1-2):67-81.
28. Lee PY, Li Z, Huang L. Thermosensitive hydrogel as a TGF-beta1 gene delivery vehicle enhances diabetic wound healing. Pharm Res 2003; 20(12):1995-2000.
29. Li Z, Ning W, Wang J, et al. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm Res 2003; 20(6):884-888.
30. Hengge UR, Chan EF, Foster RA, et al. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 1995; 10(2):161-166.
31. Hengge UR, Walker PS, Vogel JC. Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 1996; 97(12):2911-2916.
32. Meuli M, Liu Y, Liggitt D, et al. Efficient gene expression in skin wound sites following local plasmid injection. J Invest Dermatol 2001; 116(1):131-135.
33. Meng X, Sawamura D, Tamai K, et al. Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin. J Clin Invest 1998; 101(6):1462-1467.
34. Hengge UR, Dexling B, Mirmohammadsadegh A. Safety and pharmacokinetics of naked plasmid DNA in the skin: studies on dissemination and ectopic expression. J Invest Dermatol 2001; 116(6):979-982.
35. Furth PA, Shamay A, Hennighausen L. Gene transfer into mammalian cells by jet injection. Hybridoma 1995; 14(2):149-152.
36. Sawamura D, Ina S, Itai K, et al. In vivo gene introduction into keratinocytes using jet injection. Gene Ther 1999; 6(10):1785-1787.
37. Haensler J, Verdelet C, Sanchez V, et al. Intradermal DNA immunization by using jetinjectors in mice and monkeys. Vaccine 1999; 17(7-8):628-638.
38. Meilander-Lin NJ, Cheung PJ, Wilson DL, et al. Sustained in vivo gene delivery from agarose hydrogel prolongs nonviral gene expression in skin. Tissue Eng 2005; 11(3-4):546-555.
39. Eriksson E, Yao F, Svensjo T, et al. In Vivo Gene Transfer to Skin and Wound by Microseeding. Journal of Surgical Research 1998; 78(2):85-91.
40. Ciernik IF, Krayenbuhl BH, Carbone DP. Puncture-mediated gene transfer to the skin. Hum Gene Ther 1996; 7(8):893-899.
41. Klein RM, Wolf ED, Wu R, et al. High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology 1992; 24:384-386.
42. Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci U S A 1990; 87(24):9568-9572.
43. Williams RS, Johnston SA, Riedy M, et al. Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci U S A 1991; 88(7):2726-2730.
44. Dileo J, Miller TE Jr., Chesnoy S, et al. Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 2003; 14(1):79-87.
45. Fynan EF, Webster RG, Fuller DH, et al. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A 1993; 90(24):11478-11482.
46. Haynes JR, McCabe DE, Swain WF, et al. Particle-mediated nucleic acid immunization. J Biotechnol 1996; 44(1-3):37-42.
47. Andree C, Swain WF, Page CP, et al. In vivo transfer and expression of a human epidermal growth factor gene accelerates wound repair. Proc Natl Acad Sci U S A 1994; 91(25):12188-12192. www.wiley.co.uk/genmed/clinical/. July 2007.
48. www.wiley.co.uk/genmed/clinical/
49. Birchall J, Coulman S, Pearton M, et al. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch micro-fabricated micro-needles. J Drug Target 2005; 13(7):415-421.
50. Coulman S, Allender C, Birchall J. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit Rev Ther Drug Carrier Syst 2006; 23(3):205-258.
51. Henry S, McAllister DV, Allen MG, et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci 1998; 87(8):922-925.
52. Lin W, Cormier M, Samiee A, et al. Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology. Pharm Res 2001; 18(12):1789-1793.
53. Matriano JA, Cormier M, Johnson J, et al. Macroflux microprojection array patch technology:a new and efficient approach for intracutaneous immunization. Pharm Res 2002; 19(1):63-70.
54. Mikszta JA, Alarcon JB, Brittingham JM, et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 2002; 8(4):415-419.
55. Coulman SA, Barrow D, Anstey A, et al. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr Drug Deliv 2006; 3(1):65-75.
56. Cemazar M, Golzio M, Sersa G, et al. Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand? Curr Pharm Des 2006; 12(29):3817-3825.
57. Bureau MF, Gehl J, Deleuze V, et al. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474(3):353-359.
58. Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1982; 1(7):841-845.
59. Potter H, Weir L, Leder P. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci U S A 1984; 81(22):7161-7165.
60. Titomirov AV, Sukharev S, Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1991; 1088(1):131-134.
61. Suzuki T, Shin BC, Fujikura K, et al. Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 1998; 425(3):436-440.
62. Rols MP, Delteil C, Golzio M, et al. In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 1998; 16(2):168-171.
63. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16(9):867-870.
64. Mir LM, Bureau MF, Rangara R, et al. Long-term, high level in vivo gene expression after electric pulse-mediated gene transfer into skeletal muscle. C R Acad Sci III 1998; 321(11):893-899.
65. Drabick JJ, Glasspool-Malone J, King A, et al. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 2001; 3(2):249-255.
66. Glasspool-Malone J, Somiari S, Drabick JJ, et al. Efficient nonviral cutaneous transfection. Mol Ther 2000; 2(2):140-146.
67. Pavselj N, Préat V. DNA electrotransfer into the skin using a combination of one highand one low-voltage pulse. J Control Release 2005; 106(3):407-415.
68. Heller R, Schultz J, Lucas ML, et al. Intradermal delivery of interleukin-12 plasmid DNA by in vivo electroporation. DNA Cell Biol 2001; 20(1):21-26.
69. Dujardin N, Van Der Smissen P., Préat V. Topical gene transfer into rat skin using electroporation. Pharm Res 2001; 18(1):61-66.
70. Dujardin N, Staes E, Kalia Y, et al. In vivo assessment of skin electroporation using square wave pulses. J Control Release 2002; 79(1-3):219-227.
71. Maruyama H, Ataka K, Higuchi N, et al. Skin-targeted gene transfer using in vivo electroporation. Gene Ther 2001; 8(23):1808-1812.
72. Zhang L, Widera G, Rabussay D. Enhancement of the effectiveness of electroporationaugmented cutaneous DNA vaccination by a particulate adjuvant. Bioelectrochemistry 2004; 63(1-2):369-373.
73. Heller LC, Jaroszeski MJ, Coppola D, et al. Optimization of cutaneous electrically mediated plasmid DNA delivery using novel electrode. Gene Ther 2007; 14(3):275-280.
74. Byrnes CK, Malone RW, Akhter N, et al. Electroporation enhances transfection efficiency in murine cutaneous wounds. Wound Repair Regen 2004; 12(4):397-403.
75. Marti G, Ferguson M, Wang J, et al. Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model. Gene Ther 2004; 11(24):1780-1785.
76. Lin MP, Marti GP, Dieb R, et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen 2006; 14(5):618-624.
77. Medi BM, Hoselton S, Marepalli RB, et al. Skin targeted DNA vaccine delivery using electroporation in rabbits: I. Efficacy. Int J Pharm 2005; 294(1-2):53-63.
78. Medi BM, Singh J. Skin targeted DNA vaccine delivery using electroporation in rabbits:II. Safety. Int J Pharm 2006; 308(1-2):61-68.
79. Mitragotri S, Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev 2004; 56(5):589-601.
80. Kim HJ, Greenleaf JF, Kinnick RR, et al. Ultrasound-mediated transfection of mammalian cells. Hum Gene Ther 1996; 7(11):1339-1346.
81. Taniyama Y, Tachibana K, Hiraoka K, et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002; 9(6):372-380.
82. Yang L, Shirakata Y, Tamai K, et al. Microbubble-enhanced ultrasound for gene transfer into living skin equivalents. J Dermatol Sci 2005; 40(2):105-114.
83. Lentacker I, De Geest BG, Vandenbroucke RE, et al. Ultrasound-responsive polymercoated microbubbles that bind and protect DNA. Langmuir 2006; 22(17):7273-7278.
84. Sintov AC, Krymberk I, Daniel D, et al. Radiofrequency-driven skin microchanneling as a new way for electrically assisted transdermal delivery of hydrophilic drugs. J Control Release 2003; 89(2):311-320.
85. Birchall J, Coulman S, Anstey A, et al. Cutaneous gene expression of plasmid DNA in excised human skin following delivery via microchannels created by radio frequency ablation. Int J Pharm 2006; 312(1-2):15-23.
86. Tao W, Wilkinson J, Stanbridge EJ, et al. Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane. Proc Natl Acad Sci U S A 1987; 84(12):4180-4184.
87. Zeira E, Manevitch A, Khatchatouriants A, et al. Femtosecond infrared laser-an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003; 8(2):342-350.
88. Ogura M, Sato S, Nakanishi K, et al. In vivo targeted gene transfer in skin by the use of laser-induced stress waves. Lasers Surg Med 2004; 34(3):242-248.
89. Badiavas E, Mehta PP, Falanga V. Retrovirally mediated gene transfer in a skin equivalent model of chronic wounds. J Dermatol Sci 1996; 13(1):56-62.
90. Choate KA, Khavari PA. Sustainability of keratinocyte gene transfer and cell survival in vivo. Hum Gene Ther 1997; 8(8):895-901.
91. Page SM, Brownlee GG. An ex vivo keratinocyte model for gene therapy of hemophilia B. J Invest Dermatol 1997; 109(2):139-145.
92. Kolodka TM, Garlick JA, Taichman LB. Evidence for keratinocyte stem cells in vitro: long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc Natl Acad Sci U S A 1998; 95(8):4356-4361.
93. Deng H, Lin Q, Khavari PA. Sustainable cutaneous gene delivery. Nat Biotechnol 1997; 15(13):1388-1391.
94. Peroni CN, Cecchi CR, Damiani R, et al. High-level secretion of growth hormone by retrovirally transduced primary human keratinocytes: prospects for an animal model of cutaneous gene therapy. Mol Biotechnol 2006; 34(2):239-245.
95. Baldeschi C, Gache Y, Rattenholl A, et al. Genetic correction of canine dystrophic epidermolysis bullosa mediated by retroviral vectors. Hum Mol Genet 2003; 12(15):1897-1905.
96. Pfutzner W, Joari MR, Foster RA, et al. A large preclinical animal model to assess ex vivo skin gene therapy applications. Arch Dermatol Res 2006; 298(1):16-22.
97. Setoguchi Y, Jaffe HA, Danel C, et al. Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J Invest Dermatol 1994; 102(4):415-421.
98. Lu B, Scott G, Goldsmith LA. A model for keratinocyte gene therapy: preclinical and therapeutic considerations. Proc Assoc Am Physicians 1996; 108(2):165-172.
99. Lu B, Federoff HJ, Wang Y, et al. Topical application of viral vectors for epidermal gene transfer. J Invest Dermatol 1997; 108(5):803-808.
100. Jaakkola P, Ahonen M, Kahari VM, et al. Transcriptional targeting of adenoviral gene delivery into migrating wound keratinocytes using FiRE, a growth factor-inducible regulatory element. Gene Ther 2000; 7(19):1640-1647.
101. Plog MS, Guyre CA, Roberts BL, et al. Preclinical safety and biodistribution of adenovirus- based cancer vaccines after intradermal delivery. Hum Gene Ther 2006; 17(7):705-716.
102. Marchetto MC, Muotri AR, Burns DK, et al. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice. Proc Natl Acad Sci U S A 2004; 101(51):17759-17764.
103. Lillehammer T, Tveito S, Engesaeter BO, et al. Melanoma-specific expression in firstgeneration adenoviral vectors in vitro and in vivo-use of the human tyrosinase promoter with human enhancers. Cancer Gene Ther 2005; 12(11):864-872.
104. Rolland AP, Mumper RJ. Plasmid delivery to muscle: Recent advances in polymer delivery systems. Adv Drug Deliv Rev 1998; 30(1-3):151-172.
105. Hengge UR, Mirmohammadsadegh A. Adeno-associated virus expresses transgenes in hair follicles and epidermis. Mol Ther 2000; 2(3):188-194.
106. Deodato B, Arsic N, Zentilin L, et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 2002; 9(12):777-785.
107. Galeano M, Deodato B, Altavilla D, et al. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46(4):546-555.
108. Ma H, Xu R, Cheng H, et al. Gene transfer into human keloid tissue with adeno-associated virus vector. J Trauma 2003; 54(3):569-573.
109. Descamps V, Blumenfeld N, Beuzard Y, et al. Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vector. Arch Dermatol 1996; 132(10):1207-1211.
110. Kuhn U, Terunuma A, Pfutzner W, et al. In vivo assessment of gene delivery to keratinocytes by lentiviral vectors. J Virol 2002; 76(3):1496-1504.
111. Gagnoux-Palacios L, Hervouet C, Spirito F, et al. Assessment of optimal transduction of primary human skin keratinocytes by viral vectors. J Gene Med 2005; 7(9):1178-1186.